BWMN

Class action law firm Monteverde & Associates PC is investigating four proposed mergers to determine if shareholders are receiving fair deal terms. The investigations cover Bowman Consulting Group's sale to Bernhard Capital Partners ($43.00/share), Utz Brands' sale to Intersnack Group ($14.25/share with vote on Nov 13), Passage Bio's merger with Remix Therapeutics (vote on Nov 5), and Finward Bancorp's sale to First Financial Bancorp (1.35 share exchange ratio with vote on Nov 2).

Monteverde & Associates PC, a class action securities firm, is investigating four merger deals to determine if they represent fair value for shareholders: Bowman Consulting Group's sale to Bernhard Capital Partners ($43.00/share), DoubleVerify Holdings' sale to Nielsen Holdings ($13.60/share), Varex Imaging's sale to Teledyne Technologies ($18.90/share), and MarineMax's sale to Francisco Partners ($53.00/share). The firm is soliciting shareholders to evaluate whether these proposed transactions are fair.

Marsh reported Q3 2026 earnings of $2.03 per share, beating consensus estimates of $1.96, with revenues of $6.86 billion exceeding expectations. However, Marsh shares have underperformed the S&P 500 by 16.6% year-to-date.

The stock received a Zacks Rank #3 (Hold) rating with mixed estimate revisions. Bowman Consulting, another professional services firm, is expected to report earnings of $0.50 per share, representing an 18% year-over-year decline.